- cafead Aug 05, 2021 at 11:22: PM
via Nearly two months after Athira Pharma Chief Executive Officer Leen Kawas was placed on a temporary leave of absence following reports she altered images that were part of her doctoral thesis, legal firms are lining up to lead litigation against the company on behalf of shareholders who saw their stock dive.
article source
article source